.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Farmers Insurance
Novartis
Colorcon
Dow
Johnson and Johnson
McKesson
Moodys
QuintilesIMS
Cipla

Generated: December 17, 2017

DrugPatentWatch Database Preview

Mycophenolate mofetil - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for mycophenolate mofetil and what is the scope of mycophenolate mofetil patent protection?

Mycophenolate mofetil
is the generic ingredient in three branded drugs marketed by Roche Palo, Accord Hlthcare, Alkem Labs Ltd, Apotex Corp, Dr Reddys Labs Ltd, Jubilant Cadista, Mylan, Sandoz, Strides Pharma, Teva Pharms, Vintage Pharms Llc, West-ward Pharms Int, Zhejiang Hisun Pharm, Zydus Pharms Usa Inc, Apotex, Akorn Inc, Mylan Labs Ltd, and Par Sterile Products, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for mycophenolate mofetil. Twenty suppliers are listed for this compound. There is one tentative approval for this compound.

Pharmacology for mycophenolate mofetil

Tentative approvals for MYCOPHENOLATE MOFETIL

Applicant Application No. Strength Dosage Form
u► Subscribe500MGINJECTABLE; INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile ProductsMYCOPHENOLATE MOFETIL HYDROCHLORIDEmycophenolate mofetil hydrochlorideINJECTABLE;INJECTION203575-001Oct 28, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Akorn IncMYCOPHENOLATE MOFETIL HYDROCHLORIDEmycophenolate mofetil hydrochlorideINJECTABLE;INJECTION204043-001Feb 28, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs LtdMYCOPHENOLATE MOFETILmycophenolate mofetilTABLET;ORAL091249-001Nov 4, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
SandozMYCOPHENOLATE MOFETILmycophenolate mofetilTABLET;ORAL065451-001Oct 15, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdMYCOPHENOLATE MOFETILmycophenolate mofetilTABLET;ORAL090464-001Sep 13, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
MylanMYCOPHENOLATE MOFETILmycophenolate mofetilTABLET;ORAL065521-001May 4, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides PharmaMYCOPHENOLATE MOFETILmycophenolate mofetilTABLET;ORAL090456-001Jun 10, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides PharmaMYCOPHENOLATE MOFETILmycophenolate mofetilCAPSULE;ORAL090055-001Jun 10, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Vintage Pharms LlcMYCOPHENOLATE MOFETILmycophenolate mofetilCAPSULE;ORAL090111-001Dec 22, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Jubilant CadistaMYCOPHENOLATE MOFETILmycophenolate mofetilCAPSULE;ORAL090762-001Dec 15, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: mycophenolate mofetil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche PaloCELLCEPTmycophenolate mofetilCAPSULE;ORAL050722-001May 3, 1995► Subscribe► Subscribe
Roche PaloCELLCEPTmycophenolate mofetilTABLET;ORAL050723-001Jun 19, 1997► Subscribe► Subscribe
Roche PaloCELLCEPTmycophenolate mofetilSUSPENSION;ORAL050759-001Oct 1, 1998► Subscribe► Subscribe
Roche PaloCELLCEPTmycophenolate mofetilSUSPENSION;ORAL050759-001Oct 1, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Healthtrust
Medtronic
QuintilesIMS
Daiichi Sankyo
McKinsey
US Army
Fish and Richardson
Dow
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot